Special Drug Use Investigation for LAMICTAL Bipolar
Special Drug Use Investigation for LAMICTAL Bipolar
This post-marketing surveillance study is designed to collect and assess information on safety and effectiveness of lamotrigine tablets in patients with bipolar disorder in routine clinical practice.
("LAMICTAL" is a trademark of the GlaxoSmithKline group of companies.)
Inclusion Criteria:
Exclusion Criteria: